AVX vs TECH · rev $67.9K vs P/E 65, rev $1.22B
Avax One Technology Ltd. (AVX) versus Bio-Techne Corp (TECH) — a side-by-side from cached financials, not a winner call.
Avax One Technology Ltd. (AVX) is a software - infrastructure company listed on NASDAQ.
Bio-Techne Corp (TECH) is a biotechnology company listed on US.
Latest reported AVX revenue for 2024-12-31 was $67.9K. Net income was -$16.3M. Revenue was up 317.0% from 2023-12-31 to 2024-12-31. AVX currently screens at market cap $43.7M.
Latest reported TECH revenue for 2025-06-30 was $1.22B. Net income was $73.4M. Revenue was up 5.2% from 2024-06-30 to 2025-06-30. TECH currently screens at market cap $8.49B and trailing P/E 65.2.
AVX currently screens at market cap $43.7M. TECH currently screens at market cap $8.49B and trailing P/E 65.2.
Not investment advice. Open the AVX and TECH stock pages for the full models.
Not investment advice.